Scale-up/Technology Transfer
- All
- APIs
- Aseptic Processing
- cGMP Manufacture
- Cleaning Validation
- Clinical Trial Materials
- Cytotoxics and High Potency Manufacturing
- Excipients
- Extractables and Leachables
- Facilities
- Fill/Finish
- Lyophilization
- Parenterals
- Process Development
- Process Validation
- Risk Management
- Scale-up/Technology Transfer
- Solid Dosage/Creams/Ointments
-
Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News | Process Development | Scale-up/Technology Transfer
CHA Biotech Launches Global CDMO Biz
Matica Biotechnology to construct GMP facility for viral vector production in Texas.Contract Pharma Staff 12.16.20
-
Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
Sesen Bio Enters Mfg. and Supply Partnership with Qilu Pharma
Technology transfer to Qilu anticipated to be completed in mid-2021.Contract Pharma Staff 12.09.20
-
Aseptic Processing | Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Fill/Finish | Industry News | Scale-up/Technology Transfer
Recipharm Inks Covid-19 Vax Pact with Moderna
Signs of letter of intent for aseptic fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate (mRNA-1273).Contract Pharma Staff 12.01.20
-
Scale-up/Technology Transfer
Ensuring Quality During the Transfer and Scale Up of Rx Drugs
Defining the key parameters and considerations for a successful technology transfer.Tom Chang, President, Bora Pharmaceutical Laboratory Co. Ltd. 11.17.20
-
Scale-up/Technology Transfer
Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
Identifying, assessing and mitigating threats at every stage of the development pipeline.Joe Willmot, Application Leader, H.E.L Group 11.17.20
-
Bioanalytical Services | cGMP Manufacture | Drug Development | Scale-up/Technology Transfer
CDMOs: Keeping up with Science & Technology
Enhancing the development of increasingly advanced and complex drug candidates is needed to drive growth in the industry.Online Exclusives Kristin Brooks, Contract Pharma 11.12.20
-
cGMP Manufacture | Fill/Finish | Scale-up/Technology Transfer
Ramping Up COVID-19 Vaccine Fill and Finish Capacity
As a partner to the U.S. Government, GRAM's newest facility was designed to increase large-scale fill and finish capacity with room to expand as demand grows.Online Exclusives Kristin Brooks, Contract Pharma 11.03.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Scale-up/Technology Transfer
Catalent, BrainStorm Enter ALS Drug Manufacturing Pact
Catalent will undertake the transfer of the manufacturing process to, and provide future cGMP clinical supply of NurOwn from its Houston facility.Contract Pharma Staff 10.22.20
-
Breaking News | cGMP Manufacture | Formulation Development | Industry News | Scale-up/Technology Transfer
Catalent Launches OneXpress Solution
Aims to accelerate a program’s transition from early-phase development to commercial-ready manufacturing for oral dosage products.Contract Pharma Staff 10.01.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Fill/Finish | Industry News | Scale-up/Technology Transfer
GRAM, J&J Enter COVID-19 Vax Manufacturing Pact
GRAM to provide advanced aseptic fill and finish services for supply of J&J’s SARS-CoV-2 vaccine candidate from its facility in Grand Rapids, MI.Contract Pharma Staff 09.25.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Scale-up/Technology Transfer
T-knife, Catalent Sign Tech Transfer and Mfg. Pact for Cell Therapy
Catalent to provide technology transfer and cGMP clinical manufacture of T-knife’s T1367 T-cell receptor program at its site in Gosselies, Belgium.Contract Pharma Staff 09.21.20
-
Breaking News | Scale-up/Technology Transfer
Natoli NP-RD30 Included at Diosna ProcessLab
Helps solve formulation and scale-up challenges.Contract Pharma Staff 09.18.20
-
Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer
Lilly, Amgen Enter Antibody Mfg. Pact for COVID-19 Therapies
Aims to significantly increase the supply capacity available for Lilly's potential COVID-19 therapies.Contract Pharma Staff 09.17.20
-
cGMP Manufacture | Collaborations & Alliances | Drug Development | Scale-up/Technology Transfer
Roche, Regeneron Partner to Increase Global Supply of REGN-COV2
To develop, manufacture and distribute REGN-COV2, Regeneron’s investigational antiviral antibody combination to treat COVID-19.Contract Pharma Staff 08.19.20
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Industry News | Scale-up/Technology Transfer
AGC Biologics, Novavax Expand Coronavirus Vax Pact
Expands supply of Matrix-M adjuvant for Novavax’ coronavirus vaccine, NVX-CoV2373, from its facility in Seattle for U.S. supply.Contract Pharma Staff 08.11.20
-
Bioassay Development | Breaking News | Collaborations & Alliances | Scale-up/Technology Transfer
Avacta Partners with BBI Solutions
BBI will manufacture the rapid SARS-CoV-2 antigen test that is being developed.Contract Pharma Staff 08.07.20
-
Breaking News | cGMP Manufacture | Scale-up/Technology Transfer
Irisys to Manufacture BioCorRx's Opioid Use Disorder Treatment
BICX102 can help prevent relapse following opioid detoxification.Contract Pharma Staff 07.31.20
-
Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer
Kodiak, Lonza Sign Long-Term Manufacturing Contract
Lonza will support scale up and secure supply chain for KSI-301, an Antibody Biopolymer Conjugate for retinal vascular diseases.Contract Pharma Staff 07.28.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Drug Development | Industry News | Scale-up/Technology Transfer
AGC Biologics, Molecular Partners to Develop DARPin Anti-COVID-19 Program
AGC Biologics will manufacture MP0420 at 100 liter and 1,000 liter scales for development and initial global supply.Contract Pharma Staff 07.09.20
-
Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer
Novavax Awarded $1.6B from Operation Warp Speed
Supports late-stage clinical development, large-scale manufacturing of NVX-CoV2373, including production of 100 million doses starting in late 2020.Contract Pharma Staff 07.07.20
